Idexx Laboratories Ord Shs (IDXX)

$338.47 3.33 (0.99%)

19:55 EDT IDXX Stock Quote Delayed 30 Minutes

Volume:

Previous Close $338.47

Market Cap 29.40B

PE Ratio 106.44

EPS 3.18

Volume (Avg. Vol.) 360,300

Day's Range 329.69 - 339.07

52-Week Range 168.65 - 345.40

Dividend & Yield N/A (N/A)

IDXX Stock Predictions, Articles, and Idexx Laboratories Ord Shs News

From InvestorPlace
From the Web

These 7 Pet Care Stocks Will Reduce the Cost of Pet Ownership

By Will Ashworth, InvestorPlace Contributor Jun 18, 2020

Global pet care sales could hit $203 billion by 2025. Here are seven pet care stocks to buy from the only pet care ETF in the U.S.

10 Recession-Resistant Services Stocks to Buy

By Josh Enomoto, InvestorPlace Contributor Jan 22, 2020

Seemingly every day, the fundamentals surrounding the U.S. economy seem to deteriorate. Nevertheless, these services-related stocks to buy offer a contrarian way to profit from the weakness.

3 Big Stock Charts for Tuesday: Costco, IDEXX Laboratories, and Ulta Beauty

By Vince Martin, InvestorPlace Contributor Nov 26, 2019

Tuesday's big stock charts look at 3 names that could reverse if market strength continues.

The Top 8 Tech Stocks of 2019 (So Far)

By Luke Lango, InvestorPlace Markets Analyst Jun 26, 2019

The stock market is off to its best year since 1997, and these tech stocks are leading that record rally. Here's what you should know.

Nasdaq ETF Hits New Highs: 5 Stocks Up More Than 50%

By Zacks Investment Research Aug 28, 2018

Though most of the stocks in the Nasdaq ETF portfolio delivered strong returns so far this year, a few were the real stars, having gained more than 50%. Compare....

The Top 20 Stocks of 2018

By Luke Lango, InvestorPlace Markets Analyst Jun 12, 2018

Here's a list of the top 20 performing stocks so far in 2018, how they got here and where they are going next.

Compare Brokers

Quant Score Make IDEXX Laboratories (IDXX) a Buy

By Portfolio Grader Nov 7, 2017

The current recommendation of Buy for IDEXX Laboratories Inc (NASDAQ:IDXX) has been derived by using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing methodology. This represents no change from the previous week and is the same ranking IDXX has had from Portfolio Grader for 3 months.

4 Top Growth Picks as MedTech Battle Rages On

By Zacks Investment Research Oct 16, 2017

Trump’s Obamacare replacement saga has made growth picks great opportunities for investors in MedTech sector.

5 MedTech Stocks to Pick for Stellar Returns

By Zacks Investment Research Sep 22, 2017

While the MedTech industry has been grappling with multiple issues, these stocks with high growth potential can be great bets.

5 of the Toughest Stocks to Withstand a Downturn

By Harriet Lefton, Writer, TipRanks Sep 18, 2017

These downturn-proof stocks to buy are much tougher than most on the market. Here's why each are among the toughest stocks to own.

7 Healthcare Stocks With A-Rated Prospects

By Louis Navellier, Editor, Growth Investor Apr 21, 2017

An Obamacare replacement is back in the news, and these seven A-rated healthcare stocks are winners regardless of how it shakes out.

The 10 Best Stocks of the S&P 500 in Q1

By Jeff Reeves Mar 31, 2017

While the markets have been performing well in general for the first quarter, some of the S&P 500's best stocks have really cut loose.

Compare Brokers

3 Medical Device Stocks to Brave Policy Uncertainty (MASI, IDXX, INGN)

By Zacks Investment Research Mar 17, 2017

These medical device stocks are primed to take advantage of the lifting of some rules and regulations out of Washington

Idexx Laboratories, Inc. (IDXX) Stock Is for the Birds … And Dogs and Cats

By Louis Navellier, Editor, Growth Investor Mar 10, 2017

With U.S. spending on our furry friends continuing to climb, Idexx Laboratories is well positioned for long-term growth and IDXX stock is worth a look.